Related Experiment Video
Updated: Jun 10, 2026
08:29
An Open Source Technology Platform to Manufacture Hydrogel-Based 3D Culture Models in an Automated and Standardized Fashion
Published on: March 31, 2022
Inaccuracy in clinical trials: effects and methods to control inaccuracy
1Center for Psychological Consultation, 22 North Harwood, Madison, WI 53717, USA. kobak@charter.net
Current Alzheimer Research
|August 14, 2010
Summary
Clinical trials for Alzheimer's disease face challenges due to inconsistent clinician rating scales. Improving rater training and using independent raters can enhance reliability and reduce trial failures.
Area of Science:
- Neuroscience
- Clinical Trials
- Gerontology
Background:
- Clinical trials for mood and anxiety disorders have a high failure rate, a trend now observed in Alzheimer's disease research.
- Issues with clinician rating scales, including poor inter-rater reliability, interview quality, and rater bias, are contributing factors.
- Problematic inter-rater reliability in Alzheimer's studies persists even with less subjective measures, often due to a lack of standardized administration and scoring.
Purpose of the Study:
- To identify key factors contributing to the high failure rate of clinical trials in Alzheimer's disease.
- To explore the impact of clinician rating scale administration on trial outcomes.
- To propose potential solutions for improving the reliability and validity of Alzheimer's clinical trials.
Main Methods:
- Analysis of factors affecting clinician rating scale administration in Alzheimer's studies.
- Review of existing literature on inter-rater reliability and rater bias in clinical trials.
- Evaluation of remediation strategies, including training, calibration, and centralized raters.
Main Results:
- Poor inter-rater reliability, interview quality, and rater bias significantly impact Alzheimer's trial outcomes.
- Lack of standardization in scale administration and scoring is a primary cause of unreliability.
- While improved training can help, ongoing calibration is necessary to prevent rater drift.
- Expectancy bias and baseline score inflation are difficult to remediate and increase placebo response.
- Centralized, independent raters may help mitigate site-specific issues.
Conclusions:
- Addressing methodological issues in clinician rating scales is crucial for improving Alzheimer's clinical trial success rates.
- Implementing standardized procedures, enhanced rater training, and independent central raters are recommended strategies.
- Further research into novel approaches is warranted, as the cost of methodological improvement should be offset by reduced trial failures.
Related Concept Videos
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:29Bias in Epidemiological Studies
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
01:13Accuracy and Errors in Hypothesis Testing
Hypothesis testing is a fundamental statistical tool that begins with the assumption that the null hypothesis H0 is true. During this process, two types of errors can occur: Type I and Type II. A Type I error refers to the incorrect rejection of a true null hypothesis, while a Type II error involves the failure to reject a false null hypothesis.
In hypothesis testing, the probability of making a Type I error, denoted as α, is commonly set at 0.05. This significance level indicates a 5% chance...
In hypothesis testing, the probability of making a Type I error, denoted as α, is commonly set at 0.05. This significance level indicates a 5% chance...
01:15Systematic Error: Methodological and Sampling Errors
In the case of systematic errors, the sources can be identified, and the errors can be subsequently minimized by addressing these sources. According to the source, systematic errors can be divided into sampling, instrumental, methodological, and personal errors.
Sampling errors originate from improper sampling methods or the wrong sample population. These errors can be minimized by refining the sampling strategy. Defective instruments or faulty calibrations are the sources of instrumental...
Sampling errors originate from improper sampling methods or the wrong sample population. These errors can be minimized by refining the sampling strategy. Defective instruments or faulty calibrations are the sources of instrumental...
01:25Errors occurring during blood pressure monitoring
Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
Several factors...